Home
- Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P.
- Natrol Appoints Vincent Andrich VP Sales for Prolab Division
- Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results
- Body Shop Reports 24.8 Mil Euro Sales Revenues
- Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label
- Supplement Group Targets Consumer Education
- Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing
- ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market
- Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products
- Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth
- Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities
- ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products
- Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace
- Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO
- drugstore.com Expects to Reach Profitability Target in 2003
- Human Genome Project Leads to Innovative Healthcare
- NPIcenter’s Career Center targets nutraceutical Industry
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Editorial: An Exercise in Synergy
- NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway
- Natural Health Trends Corp. Launches Lexxus Taiwan
- FDA Presents Compliance Guide for Structure/Function Claims
- New TrimFit® Bars Redefine Energy Bar Category
- New TrimFit® Bars Redefine Energy Bar Category
- Probiata® Offers Safe, Natural and Effective Alternative
- Alive & Well with Michelle Harris
- Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com
- Consumers Search for Healthy Cleaning Products That Work
- Nordic Naturals: Omega 3 Fatty Acids
- Cyanotech Names Bob Capelli as Director of Sales
- Bastyr University Begins New NIH Research on Mushrooms to Treat Cancer
Bastyr partners with the University of Minnesota on 3-year grant studying turkey tail mushroom and immune response in treating breast and prostate cancers with Bastyr's portion of the three-year award totalling $792,000.
- Bastyr University Begins New NIH Research on Mushrooms to Treat Cancer
Bastyr partners with the University of Minnesota on 3-year grant studying turkey tail mushroom and immune response in treating breast and prostate cancers with Bastyr's portion of the three-year award totalling $792,000.
- FDA Issues Information for Consumers about Claims for Green Tea and Certain Cancers
Agency announces the results of a review of qualified health claims that green tea may reduce the risk of certain types of cancer, considers it unlikely that green tea reduces cancer risk, considers exercising enforcement discretion.
- FDA Issues Information for Consumers about Claims for Green Tea and Certain Cancers
Agency announces the results of a review of qualified health claims that green tea may reduce the risk of certain types of cancer, considers it unlikely that green tea reduces cancer risk, considers exercising enforcement discretion.
- FDA Issues Information for Consumers about Claims for Green Tea and Certain Cancers
Agency announces the results of a review of qualified health claims that green tea may reduce the risk of certain types of cancer, considers it unlikely that green tea reduces cancer risk, considers exercising enforcement discretion.
- FDA Issues Information for Consumers about Claims for Green Tea and Certain Cancers
Agency announces the results of a review of qualified health claims that green tea may reduce the risk of certain types of cancer, considers it unlikely that green tea reduces cancer risk, considers exercising enforcement discretion.
- Indena Presents New Possibilities From Colchicine Derivatives for Cancer Treatment
Ezio Bombardelli, President of the Indena Scientific Board, presented “Colchicine and its analogues as potential anticancer drugs”, describing dimeric derivatives of thiocolchicine and activity against cellular lines of colon cancer resistant to treatment with cisplatinum.
- Indena Presents New Possibilities From Colchicine Derivatives for Cancer Treatment
Ezio Bombardelli, President of the Indena Scientific Board, presented “Colchicine and its analogues as potential anticancer drugs”, describing dimeric derivatives of thiocolchicine and activity against cellular lines of colon cancer resistant to treatment with cisplatinum.
- Indena Presents New Possibilities From Colchicine Derivatives for Cancer Treatment
Ezio Bombardelli, President of the Indena Scientific Board, presented “Colchicine and its analogues as potential anticancer drugs”, describing dimeric derivatives of thiocolchicine and activity against cellular lines of colon cancer resistant to treatment with cisplatinum.
- Indena Presents New Possibilities From Colchicine Derivatives for Cancer Treatment
Ezio Bombardelli, President of the Indena Scientific Board, presented “Colchicine and its analogues as potential anticancer drugs”, describing dimeric derivatives of thiocolchicine and activity against cellular lines of colon cancer resistant to treatment with cisplatinum.
- Indena Presents New Possibilities From Colchicine Derivatives for Cancer Treatment
Ezio Bombardelli, President of the Indena Scientific Board, presented “Colchicine and its analogues as potential anticancer drugs”, describing dimeric derivatives of thiocolchicine and activity against cellular lines of colon cancer resistant to treatment with cisplatinum.
- Sabinsa Invites Noted Researcher to Discuss Role of Turmeric-Derived Curcuminoids in Treatment of Cancer at SupplySide West
Company will be hosting a VendorWorks presentation entitled "Curcuminoids: Fighting Cancer Naturally" on Thursday, November 10, 2005 from 11 - 11:50 a.m. in the Bellini Ballroom room #2004 at the SupplySide West International Tradeshow and Conference at the Venetian Hotel & Sands Expo.
- Sabinsa Invites Noted Researcher to Discuss Role of Turmeric-Derived Curcuminoids in Treatment of Cancer at SupplySide West
Company will be hosting a VendorWorks presentation entitled "Curcuminoids: Fighting Cancer Naturally" on Thursday, November 10, 2005 from 11 - 11:50 a.m. in the Bellini Ballroom room #2004 at the SupplySide West International Tradeshow and Conference at the Venetian Hotel & Sands Expo.
- Sabinsa Invites Noted Researcher to Discuss Role of Turmeric-Derived Curcuminoids in Treatment of Cancer at SupplySide West
Company will be hosting a VendorWorks presentation entitled "Curcuminoids: Fighting Cancer Naturally" on Thursday, November 10, 2005 from 11 - 11:50 a.m. in the Bellini Ballroom room #2004 at the SupplySide West International Tradeshow and Conference at the Venetian Hotel & Sands Expo.
- Sabinsa Invites Noted Researcher to Discuss Role of Turmeric-Derived Curcuminoids in Treatment of Cancer at SupplySide West
Company will be hosting a VendorWorks presentation entitled "Curcuminoids: Fighting Cancer Naturally" on Thursday, November 10, 2005 from 11 - 11:50 a.m. in the Bellini Ballroom room #2004 at the SupplySide West International Tradeshow and Conference at the Venetian Hotel & Sands Expo.
- Sabinsa Invites Noted Researcher to Discuss Role of Turmeric-Derived Curcuminoids in Treatment of Cancer at SupplySide West
Company will be hosting a VendorWorks presentation entitled "Curcuminoids: Fighting Cancer Naturally" on Thursday, November 10, 2005 from 11 - 11:50 a.m. in the Bellini Ballroom room #2004 at the SupplySide West International Tradeshow and Conference at the Venetian Hotel & Sands Expo.
- Ribbon Nutrition Is Turning the Fight Against Breast Cancer Upside Down
Ribbon Nutrition has recently begun rolling out its line of premium dietary supplements in health food stores, with product bottles displayed upside-down. The company has launched a line of 40 dietary supplement products, including Fish Oil, Earth Energy Multi-Vitamin, Pre-Natal Plus DHA, and Core Antioxidant, and is donating up to 10% of total company revenues to their non-profit partners in the fight against breast cancer.
- Ribbon Nutrition Is Turning the Fight Against Breast Cancer Upside Down
Ribbon Nutrition has recently begun rolling out its line of premium dietary supplements in health food stores, with product bottles displayed upside-down. The company has launched a line of 40 dietary supplement products, including Fish Oil, Earth Energy Multi-Vitamin, Pre-Natal Plus DHA, and Core Antioxidant, and is donating up to 10% of total company revenues to their non-profit partners in the fight against breast cancer.
- Ribbon Nutrition Is Turning the Fight Against Breast Cancer Upside Down
Ribbon Nutrition has recently begun rolling out its line of premium dietary supplements in health food stores, with product bottles displayed upside-down. The company has launched a line of 40 dietary supplement products, including Fish Oil, Earth Energy Multi-Vitamin, Pre-Natal Plus DHA, and Core Antioxidant, and is donating up to 10% of total company revenues to their non-profit partners in the fight against breast cancer.
- Ribbon Nutrition Is Turning the Fight Against Breast Cancer Upside Down
Ribbon Nutrition has recently begun rolling out its line of premium dietary supplements in health food stores, with product bottles displayed upside-down. The company has launched a line of 40 dietary supplement products, including Fish Oil, Earth Energy Multi-Vitamin, Pre-Natal Plus DHA, and Core Antioxidant, and is donating up to 10% of total company revenues to their non-profit partners in the fight against breast cancer.
- Ribbon Nutrition Is Turning the Fight Against Breast Cancer Upside Down
Ribbon Nutrition has recently begun rolling out its line of premium dietary supplements in health food stores, with product bottles displayed upside-down. The company has launched a line of 40 dietary supplement products, including Fish Oil, Earth Energy Multi-Vitamin, Pre-Natal Plus DHA, and Core Antioxidant, and is donating up to 10% of total company revenues to their non-profit partners in the fight against breast cancer.
- Ribbon Nutrition Is Turning the Fight Against Breast Cancer Upside Down
Ribbon Nutrition has recently begun rolling out its line of premium dietary supplements in health food stores, with product bottles displayed upside-down. The company has launched a line of 40 dietary supplement products, including Fish Oil, Earth Energy Multi-Vitamin, Pre-Natal Plus DHA, and Core Antioxidant, and is donating up to 10% of total company revenues to their non-profit partners in the fight against breast cancer.
- Ribbon Nutrition Is Turning the Fight Against Breast Cancer Upside Down
Ribbon Nutrition has recently begun rolling out its line of premium dietary supplements in health food stores, with product bottles displayed upside-down. The company has launched a line of 40 dietary supplement products, including Fish Oil, Earth Energy Multi-Vitamin, Pre-Natal Plus DHA, and Core Antioxidant, and is donating up to 10% of total company revenues to their non-profit partners in the fight against breast cancer.
- Ribbon Nutrition Is Turning the Fight Against Breast Cancer Upside Down
Ribbon Nutrition has recently begun rolling out its line of premium dietary supplements in health food stores, with product bottles displayed upside-down. The company has launched a line of 40 dietary supplement products, including Fish Oil, Earth Energy Multi-Vitamin, Pre-Natal Plus DHA, and Core Antioxidant, and is donating up to 10% of total company revenues to their non-profit partners in the fight against breast cancer.
- Ribbon Nutrition Is Turning the Fight Against Breast Cancer Upside Down
Ribbon Nutrition has recently begun rolling out its line of premium dietary supplements in health food stores, with product bottles displayed upside-down. The company has launched a line of 40 dietary supplement products, including Fish Oil, Earth Energy Multi-Vitamin, Pre-Natal Plus DHA, and Core Antioxidant, and is donating up to 10% of total company revenues to their non-profit partners in the fight against breast cancer.
- Embria's SupplySide West Presentation Spotlights Story Behind Immune Health Ingredient, Epicor
Company will be hosting a VendorWorks Presentation entitled "The Discovery of a Novel Immune Modulatory Agent: EpiCor," on Friday, Oct. 20, 2006 from 11 - 11:50 a.m. at the SupplySide West International Tradeshow and Conference in Las Vegas at the Venetian Hotel in Toscana Room #3601-3604, 3610.
- Embria's SupplySide West Presentation Spotlights Story Behind Immune Health Ingredient, Epicor
Company will be hosting a VendorWorks Presentation entitled "The Discovery of a Novel Immune Modulatory Agent: EpiCor," on Friday, Oct. 20, 2006 from 11 - 11:50 a.m. at the SupplySide West International Tradeshow and Conference in Las Vegas at the Venetian Hotel in Toscana Room #3601-3604, 3610.
- Embria's SupplySide West Presentation Spotlights Story Behind Immune Health Ingredient, Epicor
Company will be hosting a VendorWorks Presentation entitled "The Discovery of a Novel Immune Modulatory Agent: EpiCor," on Friday, Oct. 20, 2006 from 11 - 11:50 a.m. at the SupplySide West International Tradeshow and Conference in Las Vegas at the Venetian Hotel in Toscana Room #3601-3604, 3610.
- Embria's SupplySide West Presentation Spotlights Story Behind Immune Health Ingredient, Epicor
Company will be hosting a VendorWorks Presentation entitled "The Discovery of a Novel Immune Modulatory Agent: EpiCor," on Friday, Oct. 20, 2006 from 11 - 11:50 a.m. at the SupplySide West International Tradeshow and Conference in Las Vegas at the Venetian Hotel in Toscana Room #3601-3604, 3610.
- Embria's SupplySide West Presentation Spotlights Story Behind Immune Health Ingredient, Epicor
Company will be hosting a VendorWorks Presentation entitled "The Discovery of a Novel Immune Modulatory Agent: EpiCor," on Friday, Oct. 20, 2006 from 11 - 11:50 a.m. at the SupplySide West International Tradeshow and Conference in Las Vegas at the Venetian Hotel in Toscana Room #3601-3604, 3610.
- Embria's SupplySide West Presentation Spotlights Story Behind Immune Health Ingredient, Epicor
Company will be hosting a VendorWorks Presentation entitled "The Discovery of a Novel Immune Modulatory Agent: EpiCor," on Friday, Oct. 20, 2006 from 11 - 11:50 a.m. at the SupplySide West International Tradeshow and Conference in Las Vegas at the Venetian Hotel in Toscana Room #3601-3604, 3610.
- Embria's SupplySide West Presentation Spotlights Story Behind Immune Health Ingredient, Epicor
Company will be hosting a VendorWorks Presentation entitled "The Discovery of a Novel Immune Modulatory Agent: EpiCor," on Friday, Oct. 20, 2006 from 11 - 11:50 a.m. at the SupplySide West International Tradeshow and Conference in Las Vegas at the Venetian Hotel in Toscana Room #3601-3604, 3610.
- FDA Warns Individuals and Firms to Stop Selling Fake Cancer 'Cures'
Warning Letters have been sent to 23 U.S. companies and two foreign individuals marketing a wide range of products fraudulently claiming to prevent and cure cancer, according to the U.S. Food and Drug Administration.
- FDA Warns Individuals and Firms to Stop Selling Fake Cancer 'Cures'
Warning Letters have been sent to 23 U.S. companies and two foreign individuals marketing a wide range of products fraudulently claiming to prevent and cure cancer, according to the U.S. Food and Drug Administration.
- FDA Warns Individuals and Firms to Stop Selling Fake Cancer 'Cures'
Warning Letters have been sent to 23 U.S. companies and two foreign individuals marketing a wide range of products fraudulently claiming to prevent and cure cancer, according to the U.S. Food and Drug Administration.
- Research Presented at the AHCC International Research Symposium Shows Potential Cancer Preventative Effects
The 16th International AHCC® (Active Hexose Correlated Compound) Symposium was held in Sapporo, Japan on July 26th and 27th, attended by over 300 medical doctors and researchers from around the world that presented and discussed research studies completed with AHCC. Researchers at Yale, in collaboration with researchers in Japan, have confirmed that AHCC significantly enhances the immune system in a manner that may prove significant for healthy immune function and as a cancer preventative for older Americans.
- Research Presented at the AHCC International Research Symposium Shows Potential Cancer Preventative Effects
The 16th International AHCC® (Active Hexose Correlated Compound) Symposium was held in Sapporo, Japan on July 26th and 27th, attended by over 300 medical doctors and researchers from around the world that presented and discussed research studies completed with AHCC. Researchers at Yale, in collaboration with researchers in Japan, have confirmed that AHCC significantly enhances the immune system in a manner that may prove significant for healthy immune function and as a cancer preventative for older Americans.
- Research Presented at the AHCC International Research Symposium Shows Potential Cancer Preventative Effects
The 16th International AHCC® (Active Hexose Correlated Compound) Symposium was held in Sapporo, Japan on July 26th and 27th, attended by over 300 medical doctors and researchers from around the world that presented and discussed research studies completed with AHCC. Researchers at Yale, in collaboration with researchers in Japan, have confirmed that AHCC significantly enhances the immune system in a manner that may prove significant for healthy immune function and as a cancer preventative for older Americans.
- Research Presented at the AHCC International Research Symposium Shows Potential Cancer Preventative Effects
The 16th International AHCC® (Active Hexose Correlated Compound) Symposium was held in Sapporo, Japan on July 26th and 27th, attended by over 300 medical doctors and researchers from around the world that presented and discussed research studies completed with AHCC. Researchers at Yale, in collaboration with researchers in Japan, have confirmed that AHCC significantly enhances the immune system in a manner that may prove significant for healthy immune function and as a cancer preventative for older Americans.
- Sabinsa's Curcumin C3 Complex(R) Subject of Recent Pancreatic Cancer Study
A recent University of Texas – MD Anderson Cancer Center study was published in the peer review American Association for Cancer Research's journal "Clinical Cancer Research" 14.14 (July 2008). Results of an eight-week human, phase II trial of the patented ingredient Curcumin C3 Complex(R) by Sabinsa, indicated orally-ingested curcumin is well-tolerated in pancreatic cancer patients and, despite limited absorption, curcuminoids showed biological efficacy in some patients with pancreatic cancer.
- Sabinsa's Curcumin C3 Complex(R) Subject of Recent Pancreatic Cancer Study
A recent University of Texas – MD Anderson Cancer Center study was published in the peer review American Association for Cancer Research's journal "Clinical Cancer Research" 14.14 (July 2008). Results of an eight-week human, phase II trial of the patented ingredient Curcumin C3 Complex(R) by Sabinsa, indicated orally-ingested curcumin is well-tolerated in pancreatic cancer patients and, despite limited absorption, curcuminoids showed biological efficacy in some patients with pancreatic cancer.
- Sabinsa's Curcumin C3 Complex(R) Subject of Recent Pancreatic Cancer Study
A recent University of Texas – MD Anderson Cancer Center study was published in the peer review American Association for Cancer Research's journal "Clinical Cancer Research" 14.14 (July 2008). Results of an eight-week human, phase II trial of the patented ingredient Curcumin C3 Complex(R) by Sabinsa, indicated orally-ingested curcumin is well-tolerated in pancreatic cancer patients and, despite limited absorption, curcuminoids showed biological efficacy in some patients with pancreatic cancer.
- Study Shows Phyllanthus Emblica in Capros® May Protect Against Smoke Induced Oxidative Damage
A new study in rats by Natreon, Inc. suggests that Capros®, a standardized Phyllanthus emblica fruit extract, is a high potency antioxidant which can combat the detrimental effects of cigarette smoke.
- Study Shows Phyllanthus Emblica in Capros® May Protect Against Smoke Induced Oxidative Damage
A new study in rats by Natreon, Inc. suggests that Capros®, a standardized Phyllanthus emblica fruit extract, is a high potency antioxidant which can combat the detrimental effects of cigarette smoke.
- Study Shows Phyllanthus Emblica in Capros® May Protect Against Smoke Induced Oxidative Damage
A new study in rats by Natreon, Inc. suggests that Capros®, a standardized Phyllanthus emblica fruit extract, is a high potency antioxidant which can combat the detrimental effects of cigarette smoke.
- Study Shows Phyllanthus Emblica in Capros® May Protect Against Smoke Induced Oxidative Damage
A new study in rats by Natreon, Inc. suggests that Capros®, a standardized Phyllanthus emblica fruit extract, is a high potency antioxidant which can combat the detrimental effects of cigarette smoke.
- Study Shows Phyllanthus Emblica in Capros® May Protect Against Smoke Induced Oxidative Damage
A new study in rats by Natreon, Inc. suggests that Capros®, a standardized Phyllanthus emblica fruit extract, is a high potency antioxidant which can combat the detrimental effects of cigarette smoke.
- Study Shows Phyllanthus Emblica in Capros® May Protect Against Smoke Induced Oxidative Damage
A new study in rats by Natreon, Inc. suggests that Capros®, a standardized Phyllanthus emblica fruit extract, is a high potency antioxidant which can combat the detrimental effects of cigarette smoke.
- Study Shows Phyllanthus Emblica in Capros® May Protect Against Smoke Induced Oxidative Damage
A new study in rats by Natreon, Inc. suggests that Capros®, a standardized Phyllanthus emblica fruit extract, is a high potency antioxidant which can combat the detrimental effects of cigarette smoke.
- Study Shows Phyllanthus Emblica in Capros® May Protect Against Smoke Induced Oxidative Damage
A new study in rats by Natreon, Inc. suggests that Capros®, a standardized Phyllanthus emblica fruit extract, is a high potency antioxidant which can combat the detrimental effects of cigarette smoke.
- New Complementary and Alternative Medicine Research Centers Target Stress-Related Illnesses, Obesity, Cancer, and Other Conditions
The National Institutes of Health’s National Center for Complementary and Alternative Medicine (NCCAM) has added four new Centers of Excellence for Research on Complementary and Alternative Medicine (CERCs) to its research centers program. The new centers will add to knowledge about complementary and alternative medicine (CAM) approaches and their potential in treating and preventing diseases and conditions that are common among Americans.
- New Complementary and Alternative Medicine Research Centers Target Stress-Related Illnesses, Obesity, Cancer, and Other Conditions
The National Institutes of Health’s National Center for Complementary and Alternative Medicine (NCCAM) has added four new Centers of Excellence for Research on Complementary and Alternative Medicine (CERCs) to its research centers program. The new centers will add to knowledge about complementary and alternative medicine (CAM) approaches and their potential in treating and preventing diseases and conditions that are common among Americans.
- New Complementary and Alternative Medicine Research Centers Target Stress-Related Illnesses, Obesity, Cancer, and Other Conditions
The National Institutes of Health’s National Center for Complementary and Alternative Medicine (NCCAM) has added four new Centers of Excellence for Research on Complementary and Alternative Medicine (CERCs) to its research centers program. The new centers will add to knowledge about complementary and alternative medicine (CAM) approaches and their potential in treating and preventing diseases and conditions that are common among Americans.
- New Complementary and Alternative Medicine Research Centers Target Stress-Related Illnesses, Obesity, Cancer, and Other Conditions
The National Institutes of Health’s National Center for Complementary and Alternative Medicine (NCCAM) has added four new Centers of Excellence for Research on Complementary and Alternative Medicine (CERCs) to its research centers program. The new centers will add to knowledge about complementary and alternative medicine (CAM) approaches and their potential in treating and preventing diseases and conditions that are common among Americans.
- New Complementary and Alternative Medicine Research Centers Target Stress-Related Illnesses, Obesity, Cancer, and Other Conditions
The National Institutes of Health’s National Center for Complementary and Alternative Medicine (NCCAM) has added four new Centers of Excellence for Research on Complementary and Alternative Medicine (CERCs) to its research centers program. The new centers will add to knowledge about complementary and alternative medicine (CAM) approaches and their potential in treating and preventing diseases and conditions that are common among Americans.
- New Complementary and Alternative Medicine Research Centers Target Stress-Related Illnesses, Obesity, Cancer, and Other Conditions
The National Institutes of Health’s National Center for Complementary and Alternative Medicine (NCCAM) has added four new Centers of Excellence for Research on Complementary and Alternative Medicine (CERCs) to its research centers program. The new centers will add to knowledge about complementary and alternative medicine (CAM) approaches and their potential in treating and preventing diseases and conditions that are common among Americans.
- Study Demonstrates That AHCC® is Safe in Combination With Most Chemotherapeutic Agents
A recently published study in the Journal of the Society for Integrative Oncology (Vol. 6, No. 3 (Summer), 2008: pp 105-109) by researchers at the University of Texas M.D. Anderson Cancer Center with the support of researchers from Amino Up Chemical Company in Sapporo, Japan has demonstrated that AHCC (Active Hexose Correlated Compound) can be safely used in combination with most chemotherapy agents. AHCC is a leading and commonly utilized dietary supplement for immune enhancement and cancer.
- Study Demonstrates That AHCC® is Safe in Combination With Most Chemotherapeutic Agents
A recently published study in the Journal of the Society for Integrative Oncology (Vol. 6, No. 3 (Summer), 2008: pp 105-109) by researchers at the University of Texas M.D. Anderson Cancer Center with the support of researchers from Amino Up Chemical Company in Sapporo, Japan has demonstrated that AHCC (Active Hexose Correlated Compound) can be safely used in combination with most chemotherapy agents. AHCC is a leading and commonly utilized dietary supplement for immune enhancement and cancer.
- Study Demonstrates That AHCC® is Safe in Combination With Most Chemotherapeutic Agents
A recently published study in the Journal of the Society for Integrative Oncology (Vol. 6, No. 3 (Summer), 2008: pp 105-109) by researchers at the University of Texas M.D. Anderson Cancer Center with the support of researchers from Amino Up Chemical Company in Sapporo, Japan has demonstrated that AHCC (Active Hexose Correlated Compound) can be safely used in combination with most chemotherapy agents. AHCC is a leading and commonly utilized dietary supplement for immune enhancement and cancer.
- Study Demonstrates That AHCC® is Safe in Combination With Most Chemotherapeutic Agents
A recently published study in the Journal of the Society for Integrative Oncology (Vol. 6, No. 3 (Summer), 2008: pp 105-109) by researchers at the University of Texas M.D. Anderson Cancer Center with the support of researchers from Amino Up Chemical Company in Sapporo, Japan has demonstrated that AHCC (Active Hexose Correlated Compound) can be safely used in combination with most chemotherapy agents. AHCC is a leading and commonly utilized dietary supplement for immune enhancement and cancer.
- World's Top Cancer Research Body Sponsors Cold-FX® Trial
CV Technologies Inc., has announced that COLD-FX® will be the focus of a landmark U.S. National Cancer Institute (NCI) sponsored trial involving chronic lymphocytic leukemia patients – the first time the natural medicine will be part of a clinical study associated with cancer. The NCI, part of the U.S. National Institutes of Health, is the world’s most prestigious cancer research body. The trial will be conducted by American cancer and infectious diseases experts at Wake Forest University School of Medicine in Winston-Salem, North Carolina.
- World's Top Cancer Research Body Sponsors Cold-FX® Trial
CV Technologies Inc., has announced that COLD-FX® will be the focus of a landmark U.S. National Cancer Institute (NCI) sponsored trial involving chronic lymphocytic leukemia patients – the first time the natural medicine will be part of a clinical study associated with cancer. The NCI, part of the U.S. National Institutes of Health, is the world’s most prestigious cancer research body. The trial will be conducted by American cancer and infectious diseases experts at Wake Forest University School of Medicine in Winston-Salem, North Carolina.
- World's Top Cancer Research Body Sponsors Cold-FX® Trial
CV Technologies Inc., has announced that COLD-FX® will be the focus of a landmark U.S. National Cancer Institute (NCI) sponsored trial involving chronic lymphocytic leukemia patients – the first time the natural medicine will be part of a clinical study associated with cancer. The NCI, part of the U.S. National Institutes of Health, is the world’s most prestigious cancer research body. The trial will be conducted by American cancer and infectious diseases experts at Wake Forest University School of Medicine in Winston-Salem, North Carolina.
- World's Top Cancer Research Body Sponsors Cold-FX® Trial
CV Technologies Inc., has announced that COLD-FX® will be the focus of a landmark U.S. National Cancer Institute (NCI) sponsored trial involving chronic lymphocytic leukemia patients – the first time the natural medicine will be part of a clinical study associated with cancer. The NCI, part of the U.S. National Institutes of Health, is the world’s most prestigious cancer research body. The trial will be conducted by American cancer and infectious diseases experts at Wake Forest University School of Medicine in Winston-Salem, North Carolina.
- World's Top Cancer Research Body Sponsors Cold-FX® Trial
CV Technologies Inc., has announced that COLD-FX® will be the focus of a landmark U.S. National Cancer Institute (NCI) sponsored trial involving chronic lymphocytic leukemia patients – the first time the natural medicine will be part of a clinical study associated with cancer. The NCI, part of the U.S. National Institutes of Health, is the world’s most prestigious cancer research body. The trial will be conducted by American cancer and infectious diseases experts at Wake Forest University School of Medicine in Winston-Salem, North Carolina.
- World's Top Cancer Research Body Sponsors Cold-FX® Trial
CV Technologies Inc., has announced that COLD-FX® will be the focus of a landmark U.S. National Cancer Institute (NCI) sponsored trial involving chronic lymphocytic leukemia patients – the first time the natural medicine will be part of a clinical study associated with cancer. The NCI, part of the U.S. National Institutes of Health, is the world’s most prestigious cancer research body. The trial will be conducted by American cancer and infectious diseases experts at Wake Forest University School of Medicine in Winston-Salem, North Carolina.
- World's Top Cancer Research Body Sponsors Cold-FX® Trial
CV Technologies Inc., has announced that COLD-FX® will be the focus of a landmark U.S. National Cancer Institute (NCI) sponsored trial involving chronic lymphocytic leukemia patients – the first time the natural medicine will be part of a clinical study associated with cancer. The NCI, part of the U.S. National Institutes of Health, is the world’s most prestigious cancer research body. The trial will be conducted by American cancer and infectious diseases experts at Wake Forest University School of Medicine in Winston-Salem, North Carolina.
- World's Top Cancer Research Body Sponsors Cold-FX® Trial
CV Technologies Inc., has announced that COLD-FX® will be the focus of a landmark U.S. National Cancer Institute (NCI) sponsored trial involving chronic lymphocytic leukemia patients – the first time the natural medicine will be part of a clinical study associated with cancer. The NCI, part of the U.S. National Institutes of Health, is the world’s most prestigious cancer research body. The trial will be conducted by American cancer and infectious diseases experts at Wake Forest University School of Medicine in Winston-Salem, North Carolina.
- Calcium May Only Protect Against Colorectal Cancer in Presence of Magnesium
According to data presented at the American Association for Cancer Research's Seventh Annual International Conference on Frontiers in Cancer Prevention Research, an understanding of the relationship between calcium and magnesium may lead to new avenues of personalized prevention for colorectal cancer.
- Calcium May Only Protect Against Colorectal Cancer in Presence of Magnesium
According to data presented at the American Association for Cancer Research's Seventh Annual International Conference on Frontiers in Cancer Prevention Research, an understanding of the relationship between calcium and magnesium may lead to new avenues of personalized prevention for colorectal cancer.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Another Reason to Choose Healthy Lifestyle Habits
- Another Reason to Choose Healthy Lifestyle Habits
|
It has been widely accepted that head and neck cancers are best prevented by avoiding alcohol and tobacco, but now there is more evidence that eating a healthy diet can also help. A new study found that people with the highest intake of fruits and vegetables had the lowest risk of head and neck cancers.
The study, published in the International Journal of Cancer, used data collected through the National Institutes of Health–American Association of Retired Persons (NIH–AARP) Diet and Health Study. Information about diet and health-related behaviors from more than 490,000 people from the larger study, all 50 to 71 years old, was included in the new study.
Eating vegetables and fruits protects the mouth and throat
During four to five years of follow-up, 787 people were diagnosed with head and neck cancers, which include cancers of the mouth, throat, and larynx. People who ate the most fruits and vegetables were the least likely to develop head and neck cancers: their risk was 29% lower than in people with the lowest intake, who had the highest risk. A closer analysis revealed that vegetables were more protective than whole fruits, and fruit juice had no protective effect.
The following fruits and vegetables appeared to be especially protective against head and neck cancers: legumes (beans, lentils, and peas), fruits in the rose family (apples, pears, peaches, nectarines, plums, and strawberries), fruits in the nightshade family (tomatoes and peppers), and carrots.
How much and how many servings?
The people with the lowest fruit and vegetable intake were eating an average of 1.5 servings per 1,000 calories every day. Since a typical older adult eats about 1,900 calories per day, this translates to 2.85 servings per day. People with the highest intake and lowest risk of head and neck cancer were eating 5.8 servings per 1,000 calories per day, or about 11.2 servings daily—a little more than the 5 to 9 servings per day recommended by the US Department of Agriculture (USDA) in its Food Guide Pyramid.
The USDA defines a serving as half a cup of cooked legumes, one medium-sized fresh fruit, half a cup of cut fruit, one cup of raw leafy vegetables like lettuce, or half a cup of other cooked or raw vegetables.
Eat them for good health
“Quitting smoking and limiting alcohol use protects against head and neck cancer,” commented lead study author Dr. Neal Freedman of the National Cancer Institute. “Our results suggest that increasing consumption of fruit and vegetables may also contribute to reduced head and neck cancer risk and add support to current dietary recommendations to increase fruit and vegetable consumption.” These same recommendations can reduce the risks of heart disease, diabetes, and other chronic diseases, including some other cancers, such as breast, colon, lung, and stomach cancers.
Maureen Williams, ND |